https://www.lymedisease.org/what-its-like-with-brain-fog/

What it’s like to live with brain fog

By Lindsey Bever, Washington Post

Haze. Slow. Drunk. Lost. These are the words some people use to describe “brain fog.”

The condition, a form of cognitive dysfunction, has been plaguing people with certain chronic illnesses for years. But now, a new wave of people with long covid are experiencing it, casting a spotlight on the often debilitating condition.

“It’s a moment where the public and the medical community are realizing that this is real. This is what happens after certain infections,” said Akiko Iwasaki, a professor of immunobiology at Yale University and a co-author of a review article on covid-19-related cognitive impairment.

READ MORE

_______________

**Comment**

Long before COVID even existed, Lyme/MSIDS patients have suffered for decades with brain fog.

Per usual, dealing with the underlying infections will either improve or ameliorate this condition all together.  Detoxing also helps as well as balancing hormones, supplementing for deficiencies, dealing with mold, MCAS, and/or any other issue that is negatively affecting the immune system.  Diet is key and certain foods alone can cause brain fog.

Like everything with Lyme/MSIDS, it’s complex.

Popular Rationalism cross-posted a post from Courageous Discourse™ with Dr. Peter McCullough & John Leake
James Lyons-Weiler Dec 13 · Popular Rationalism
It absolutely makes sense that the spike protein would cause the fibrous clots in both veins and arteries. There are a host of ACE2-expressing cells free-floating in our blood; endothelial cells slough off, for example, and some immune cells express ACE2.If O is a cell
and = is a spike protein
O=O would be a syncytium.A chain of syncytia
O=O=O=O=O
Since the spike protein causes syncytia (cells stuck together) that chains of cells could form, with fibrinogen activation, around which RBC would get caught. This would be a slow process, could happen anywhere in the body.
The reports of from Germany from pathologists studying cadavers point to these types of clots. Dr. Peter McCullough and John Leake have an article on the science of pathologic syncytia that I am cross-posting.

Pathological Syncytia Formation with mRNA Vaccines

Unintended Consequences Potentially Explain Vaccine Failure from the Outset

By Peter A. McCullough, MD, MPH

One of the curious findings from the original randomized trials of mRNA vaccines was an explosive rate of early infection after the first injection as compared with placebo. In a recent paper from Sfera et al, the description of pathological syncytia or fusion between immune cells is described: “The LNP technology, to put it simply, mimics viral envelopes with externalized phosphatidylserine (ePS), a universal “eat me” signal, that directs immune cells to engulf the particle.  (See this link for article)

An unfortunate example of this is the recent death of a baby who died of blood clots after the hospital gave him a blood transfusion using “vaccinated” blood against the parents’ wishes.  The hospital managed to “lose” the specially donated unvaccinated blood by a family friend.

________________

https://www.theepochtimes.com/health/membranous-nephropathy-after-covid-19-vaccination

Membranous Nephropathy After COVID-19 Vaccination

Spike protein induces autoimmunity against PLA2 receptor

On my last flight I was searching for a seat and a kind woman who appeared to recognize me, smiled at an open seat next to her. I sat down and learned she is married to a prominent government official with whom she was traveling. As we talked she told me her story of taking one of the mRNA COVID-19 vaccines and then developing membranous nephropathy.

This is a disorder caused by auto-antibodies directed against the phospholipase A2 receptor on podocytes, which are critical cells in the kidney’s filtration apparatus. Membranous nephropathy like so many side effects is due to the Spike protein and can occur with SARS-CoV-2 infection and with vaccination.

Ma and coworkers recently described five cases with the infection and 37 more after COVID-19 vaccination—all with the genetic vaccines except for one with a killed virus vaccine.  (See link for article and research study)

______________

Important excerpt:

The woman developed significant edema and renal failure requiring escalating treatment including rituximab. More than a year later, she is not out of the woods and may face the need for dialysis in the future. She told me her doctor was honest with her and agreed her condition was caused by the vaccine.

Unfortunately for these patients, prognosis remains uncertain, but will continue to be downplayed and denied by corrupt public health ‘authorities,’ and therefore mainstream medicine and media who continue to claim COVID ‘vaccines’ are “safe and effective,” despite being neither.

They don’t:

But they actually:

__________________

https://www.theepochtimes.com/cdc-data-vaccinated-now-make-up-majority-of-covid-19-deaths  Video Here (Approx. 6 Min)

CDC Data: Vaccinated Now Make Up Majority of COVID-19 Deaths

DAN SKORBACH

Recent data from the Centers for Disease Control and Prevention (CDC) shows that people who are vaccinated and boosted are now more likely to die from COVID-19 than the unvaccinated.

One year ago, about a third of vaccinated people were dying from COVID. But at the beginning of 2022, that number rose to 42 percent. By summer, it went over 60 percent for the adult population.  (See link for article and video)

But, the band plays on…..

https://popularrationalism.substack.com/p/pollutants-in-human-plasma-found

Pollutants in Human Plasma Found via Double-Filtration Plasmapheresis Plasma Exchange

Studies in toxicology usually study urine, feces, and other secretions and measure indirectly. Dr. Gatti, whose lab was raided for reporting detection of nanoparticles in vaccines, has a new study.

Does everyone remember Drs. Gatti and Montanari?  We flew them in from Italy in 2017 to the IPAK Vaccine Safety Conference in Pittsburgh, PA? Probably not.

To help you remember:  https://www.ageofautism.com/2018/02/the-european-medicines-agency-attacked-gatti-and-montanari-last-year-in-british-medical-journal.html

and

Earlier this year, Dr. Gatti let me know they are back up and running.

The new study is of pollutants and toxins found in the extract of eluate from double-filtration plasmapheresis plasma exchange.

The new study, by Dr. Gatti and Dr. Felix Scholkmann, is entitled:

Particles in the Eluate from Double Filtration Plasmapheresis—A Case Study Using Field Emission Scanning Electron Microscopy/Energy-Dispersive X-ray Spectroscopy (FE-SEM/EDX)

By using plasmapheresis, they found

“aflatoxin B1, chromium, lead, cadmium, arsenic, lindane, cobalt, polycyclic-aromatic-hydrocarbons, disulfoton and aluminium (listed in descending concentration).”

They also found unknown thread-like objects.

Makes me wonder if we should all detox this way once a year?

Dr. Gatti, congratulations on your new study and on surviving the attack on your lab by Italian authorities.

It should be possible to estimate the blood and body levels of compounds to which we are exposed, say, before and after vaccination.

Citation:

Scholkmann, Felix, and Antonietta M. Gatti. 2022. “Particles in the Eluate from Double Filtration Plasmapheresis—A Case Study Using Field Emission Scanning Electron Microscopy/Energy-Dispersive X-ray Spectroscopy (FE-SEM/EDX)” Compounds 2, no. 4: 367-377. https://doi.org/10.3390/compounds2040030

_______________

**Comment**

Plasmapheresis or plasma exchange, around since the 50’s, has been used to treat autoimmune conditions, blood disorders, viral infections, chronic inflammation, pulmonary fibrosis, MS, Graves’ disease, Myasthenia gravis, transverse myelitis, HIV-related neuropathy, cancer, and even Lyme/MSIDS. Plasma is extracted from your blood, treated, and then put back into the body.

The limitation of this study is it was on a singular patient who had been treated for the following chronic infections: 

  • Borrelia afzelii
  • Borrelia burgdorferi (CH)
  • Borrelia burgdorferi (USA)
  • Borrelia garinii
  • Chlamydia pneumoniae
  • Babesia divergens
  • Bartonella henselae
  • Rickettsia Helvetica
  • Rickettsia conorii
  • Rickettsia helvetica

The thread-like object in Figure 4d, however, has a similar morphology and size as a thread-like parasitic nematode (roundworm) of the superfamiliy Filarioridea. Ticks can be also infected with these filarial nematodes [59,60].

Excerpt:

The pollution of nano- and microparticles is an emerging health concern [32,61] and novel ways of quantifying the individual exposure as well as methods to remove these particles from the body are of imminent interest for preventing and treating human diseases. DFPP, possibly in combination with the application of chelating agents, might be a powerful way to remove these nano- and microparticles from the body. The analysis of the eluate with FE-SEM/EDX seems be a useful approach to proof this possibility.
In summary, our analysis of the eluate obtained from a DFPP application revealed particles and objects in the nm and µm range of different shape and chemical composition. Our study is the first to date to investigate the composition of an eluate obtained by DFPP with FE-SEM/EDX.
IMO, while plasmapheresis might certainly help Lyme/MSIDS, the organism(s) often don’t remain in the blood for long but migrate to immunopriviledged sites like the brain, synovial fluid, spine, and organs.  This is the problem with all treatments, and testing which rely on delivery via blood, and perfectly illustrates why the current CDC monotherapy is an absolute joke.  Further, it doesn’t take into account the relapsing nature of these pathogens which change forms in the body.  Savvy treatment purposely cycles antimicrobials which helps address these complex issues, which mainstream medicine/research is completely oblivious about.
This clearly illustrates why we should not give another dime to corrupt public health/research because insanity is doing the same thing over and over but expecting different results.
For more:

https://www.lymedisease.org/lyme-infected-during-basic-training/

Infected during basic training, vet urges “real” funding for Lyme disease

Paul Owen gave the following public comments to the federal Tick-Borne Disease Working Group on November 21, 2022.

Thank you for having me today and thank you for hearing my story. I am a father, husband, friend, voter in Ohio, software executive, former NCAA sprinter turned ultra-marathon runner and a US Army Veteran.

I am now also, not by choice, but by circumstance, a Lyme warrior and advocate for the Lyme and tick-borne illness community.

My own Lyme journey, unbeknownst to me, started in 1989, during Army Basic Combat Training at Ft Dix, New Jersey. I was bitten by three ticks. In my subsequent 7 years of service, tick bites were a common occurrence, including at Ft Leonard Wood, Missouri.

As a young soldier, I thought nothing of the small pests and was not trained to treat them as a threat. This just was not the priority or the science of the day. I never got sick from the bites. I never saw an unusual rash. I drove on like every other soldier. In short, those bites were non-eventful.

It was not until after a shoulder surgery in 2015 that the effects of the tick bites became clear. On a Saturday morning, I ran and won a 5k. On Monday morning, I could not walk up my own stairs. There were the literally hundreds of tests. From spinal taps, to sleep tests, to blood tests, to liver tests, brain scans, endoscopy, you name it. The results were always ‘normal’ and conducted by either general practitioners or by specialist referral.

Seven-year headache

Over the next 7+ years, symptoms have only worsened, to include extreme headache for the entire time (yes, that is a 7+ year headache), tremors, extreme fatigue, memory loss, getting ‘lost’ on routine errands like picking up the kids from school, almost weekly localized seizures, loss of hearing and extreme, prolonged and consistent pain in joints and connective tissues. All of which are common in Lyme and other tick-borne disease patients. In short, these diseases torture everyday people for months, years and decades.

Also, over that period of time, I have tried every bespoke treatment from each of these specialists. I have spent tens of thousands of dollars out of pocket for treatments, co-pays on doctors and tests.

The costs of this epidemic on families, the economy and military readiness are incalculable. Tick-borne diseases affect millions in the United States (and around the world). Over 400,000 are added to that list every year.This is exacerbated by the denial of insurance or even the existence of the problem. This not only causes great financial hardship for American families, but also a drain on the economy In addition, military personnel are some of the more vulnerable to tick-borne disease by the nature of their environments.

What needs to be done

First, we need to mandate the recognition of and clinical diagnosis of Lyme disease. The testing is widely known not to be accurate. These symptoms are real and in no other environment would we say that the symptoms do not justify the diagnosis. Failure to come up with a test does not justify the denial of a diagnosis or treatment. It’s nonsensical.

Second, insurance needs to be mandated to cover the costs of this disease like any other. That will have the effect of driving costs down, expanding the research and improving the overall health and well being of both civilian and military populations.

Lastly, we need REAL funding to create reliable testing and treatments. I’m not talking about millions, or tens of millions, or even hundreds of millions. This is an epidemic as serious as COVID, breast cancer, and AIDS–and should be funded as such with billions in research on testing and cures.

Finally, I want to thank the working group for your tireless efforts to champion this cause and to inform Congress on solutions and prioritizing this epidemic. Thank you for your time.

_______________

**Comment**

Similarly to the beliefs of this patient, the answer does not lie in giving more funding to agencies that have done nothing but further the misery of Lyme/MSIDS patients for over 40 years.

And, contrary to this excellent, “must see” video, the answer also does not lie in “medical consensus,” as this information was published nearly 4 years ago with ZERO change in this highly sought after “consensus.”  The pervasive propaganda about Lyme/MSIDS is so complete that about the only hope for truth is that the deniers contract it, so they personally fully grasp the deception; however, even that doesn’t assure understanding as thousands are coming down with COVID, experiencing adverse reactions, and even dying after getting the COVID gene therapy injections and people are still rolling up their sleeves for more!  The disconnect is surreal, but there you have it:

A lie can travel halfway around the world while the truth is putting on its shoes.

https://www.lymedisease.org/35-genes-biomarkers-lyme/

Could these 35 genes be used as biomarkers for chronic Lyme?

Nov. 15, 2022

Researchers at the Icahn School of Medicine at Mount Sinai in New York have identified 35 genes that are particularly highly expressed in people with long-term Lyme disease.

These genes could potentially be used as biomarkers to diagnose patients with the condition, which is otherwise difficult to diagnose and treat.

The findings, published November 15 in the journal Cell Reports Medicine, may also lead to new therapeutic targets.

The study is the first to use transcriptomics as a blood test to measure RNA levels in patients with long-term Lyme disease.

Lyme disease is a tick-borne illness that is not well understood. Approximately 30,000 diagnosed cases are reported to the CDC each year, but the estimated real number is closer to 476,000 cases, carrying an annual healthcare cost of about $1 billion in the United States. While most patients are diagnosed and treated with antibiotics at the earliest stages of Lyme disease, about 20 percent of the patients develop long-term complications, which could include arthritis, neurologic symptoms, and/or heart problems.

“We wanted to understand whether there is a specific immune response that can be detected in the blood of patients with long-term Lyme disease to develop better diagnostics for this debilitating disease. There still remains a critical unmet need, as this disease so often goes undiagnosed or misdiagnosed,” said Avi Ma’ayan, PhD, Professor, Pharmacological Sciences, and Director of the Mount Sinai Center for Bioinformatics at Icahn Mount Sinai, and senior author of the paper. “Not enough is understood about the molecular mechanisms of long-term Lyme disease.”

Image above: Researchers at Icahn Mount Sinai in New York identified 35 genes that could be used as biomarkers to potentially diagnose patients with long-term Lyme disease. Image credit: Cell Reports Medicine

As part of the study, RNA sequencing was conducted using blood samples from 152 patients with symptoms of post-treatment Lyme disease to measure their immune response.

Differences in gene expression

Combined with RNA sequencing data from 72 patients with acute Lyme disease and 44 uninfected controls, the investigators observed differences in gene expression. They found that most of the post-treatment Lyme disease patients had a distinctive inflammatory signature compared with the acute Lyme disease group.

In addition, by analyzing the differentially expressed genes in this study along with genes that are differentially expressed due to other infections from other published studies, the researchers identified a subset of genes that were highly expressed, which have not been previously established for this Lyme-associated inflammatory response.

Using a type of artificial intelligence called machine learning, the researchers further reduced the group of genes to establish an mRNA biomarker set capable of distinguishing healthy patients from those with acute or post-treatment Lyme disease. A gene panel that measures the expression of the genes the investigators identified could be developed as a diagnostic to test for Lyme.

A new diagnostic for Lyme?

“We should not underestimate the value of using omics technologies, including transcriptomics, to measure RNA levels to detect the presence of many complex diseases, like Lyme disease. A diagnostic for Lyme disease may not be a panacea but could represent meaningful progress toward a more reliable diagnosis and, as a result, potentially better management of this disease,” said Dr. Ma’ayan.

Next, the investigators plan to repeat the study using data from single-cell transcriptomics and whole blood, apply the machine learning approach to other complex diseases that are difficult to diagnose, and develop the diagnostic gene panel and test it on samples from patients.

The paper is titled “Gene set predictor for post-treatment Lyme Disease.” Additional co-authors are Daniel J.B. Clarke, MS (Icahn Mount Sinai, New York), and Alison W. Rebman, MPH, Jinshui Fan, MD, PhD, Mark J. Soloski, PhD, and John N. Aucott, MD, all from Johns Hopkins University of Medicine in Baltimore.

The project was partially supported by funds from the Cohen Lyme & Tickborne Disease Initiative and the National Institutes of Health.

SOURCE: MountSinai.org